Description
INLYTA 5mg Tablet 14’s inlyta 5mg tablets (14’s) is a specialized medication designed for adults with advanced renal cell carcinoma (rcc) or gastrointestinal stromal tumors (gist) who have received prior treatment. This drug, also known as sunitinib malate, works by inhibiting the growth of cancer cells, helping to slow down or stop their progression. Each tablet contains 5mg of the active ingredient, sunitinib, and is intended for oral administration. INLYTA is a crucial component in a comprehensive treatment plan for these types of cancers.
Reviews
There are no reviews yet.